Elsevier’s ClinicalPath places evidence-based oncology pathways and clinical trial support within the workflow to empower patient-centered treatment decisions for optimal patient outcomes. Developed by a national committee of academic and community oncologists, our pathways cover over 95% of the most common cancer cases in medical and radiation oncology.
ClinicalPath empowers clinicians to deliver optimal patient care:
Standardize care: Supports standardization of care among physicians in an increasingly complex field.
Provide evidence: Guides oncologists in their treatment decisions, based on the latest evidence-based research.
Prioritize clinical trials: Promotes accrual to clinical trials, with trials prioritized within each pathway. Complete the form to learn more about ClinicalPath.
Cookies are used by this site. To decline or learn more, visit our cookie notice.